Literature DB >> 16558055

Stimulation of Enterotoxin B Production II. Synthetic Medium for Staphylococcal Growth and Enterotoxin B Production.

C H Wu1, M S Bergdoll.   

Abstract

A relatively large amount of enterotoxin B (125 mug/ml) was produced in a synthetic medium composed of amino acids, inorganic salts, and vitamins. This medium was prepared on the basis of the utilization of the various amino acids by Staphylococcus aureus strain S-6 throughout the growth cycle. Arginine appeared to be essential for enterotoxin production. The pattern of enterotoxin production in the synthetic media appeared to differ from that in complex media.

Entities:  

Year:  1971        PMID: 16558055      PMCID: PMC416238          DOI: 10.1128/iai.3.6.784-792.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  6 in total

1.  Peptides and bacterial growth. IX. Release of double inhibitions with single peptides.

Authors:  H KIHARA; E E SNELL
Journal:  J Biol Chem       Date:  1960-05       Impact factor: 5.157

2.  Stimulation of enterotoxin B production I. Stimulation by fractions from a pancreatic digest of casein.

Authors:  C H Wu; M S Bergdoll
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

3.  Effects of meat-curing salts and temperature on production of staphylococcal enterotoxin B.

Authors:  R A McLean; H D Lilly; J A Alford
Journal:  J Bacteriol       Date:  1968-04       Impact factor: 3.490

4.  Nutritional requirements of Staphylococcus aureus S-6.

Authors:  R A Mah; D Y Fung; S A Morse
Journal:  Appl Microbiol       Date:  1967-07

5.  Enterotoxin B synthesis by replicating and nonreplicating cells of Staphylococcus aureus.

Authors:  Z Markus; G J Silverman
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

6.  Regulation of staphylococcal enterotoxin B.

Authors:  S A Morse; R A Mah; W J Dobrogosz
Journal:  J Bacteriol       Date:  1969-04       Impact factor: 3.490

  6 in total
  14 in total

1.  Steady-state staphylococcal enterotoxin type C mRNA is affected by a product of the accessory gene regulator (agr) and by glucose.

Authors:  L B Regassa; J L Couch; M J Betley
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

2.  Amino acid requirements for the production of enterotoxin B by Staphylococcus aureus S-6 in a chemically defined medium.

Authors:  R D Miller; D Y Fung
Journal:  Appl Microbiol       Date:  1973-05

3.  Production of staphylococcal enterotoxins A, B, and C under conditions of controlled pH and aeration.

Authors:  A W Jarvis; R C Lawrence; G G Pritchard
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

4.  Prevention of Staphylococcus aureus lysis.

Authors:  S Bhaduri
Journal:  Appl Environ Microbiol       Date:  1983-08       Impact factor: 4.792

5.  Transport and processing of staphylococcal enterotoxin B.

Authors:  R K Tweten; J J Iandolo
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

6.  Staphylococcal enterotoxin synthesis during the exponential, transitional, and stationary growth phases.

Authors:  J K Czop; M S Bergdoll
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

7.  Effect of minerals on staphylococcal enterotoxin B production.

Authors:  G M Keller; R S Hanson; M S Bergdoll
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

8.  Magnesium and iron addition to casein hydrolysate medium for production of staphylococcal enterotoxins A, B, and C.

Authors:  T N Morita; J E Patterson; M J Woodburn
Journal:  Appl Environ Microbiol       Date:  1979-07       Impact factor: 4.792

9.  Development of a minimal medium for Clostridium perfringens by using an anaerobic chemostat.

Authors:  S B Goldner; M Solberg; L S Post
Journal:  Appl Environ Microbiol       Date:  1985-08       Impact factor: 4.792

10.  Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus.

Authors:  M W Reeves; L Pine; J C Feeley; D E Wells
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.